Showing 1,341 - 1,360 results of 70,113 for search '(( 50 ((a decrease) OR (teer decrease)) ) OR ( a ((mean decrease) OR (point decrease)) ))', query time: 1.26s Refine Results
  1. 1341
  2. 1342
  3. 1343

    Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…Mean outpatient visits in the recurrence group decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”
  4. 1344

    Results of peptide toxicity of each diet. by Fatima Dikhanbayeva (11501962)

    Published 2021
    “…<p>Values are given as mean ± SD for a total of 50 animals. Control group (I) - 0.295 nm, Curd mass (II)– 0.122 nm, Curd mass with flaxseed flour (III)– 0.113 nm, curd mass with celery root powder (IV) - 0.114 nm, Curd mass with bee bread (V)– 0.127 nm. …”
  5. 1345
  6. 1346

    The results of assay of blood serum biochemical parameters after experiment. by Fatima Dikhanbayeva (11501962)

    Published 2021
    “…*Values are given as mean ± SD for a total of 50 animals. p<0, 05 versus mice fed regular diet.…”
  7. 1347
  8. 1348

    Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…In the non-recurrence group, CRT improved from 482.5 ± 112.8 to 294.7 ± 65.3, 302.0 ± 68.0, 284.7 ± 55.4, 285.3 ± 70.2, 265.2 ± 65.0, and 266.1 ± 78.2 μm at 1, 3, 6, 12, 24, and 36 months, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g006" target="_blank">Fig 6</a>).…”
  9. 1349
  10. 1350
  11. 1351

    A summary of the included study characteristics. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  12. 1352
  13. 1353
  14. 1354
  15. 1355
  16. 1356

    A change-point–based control chart for detecting sparse mean changes in high-dimensional heteroscedastic data by Zezhong Wang (15138025)

    Published 2023
    “…In this article, we propose two change-point–based control charts to detect sparse shifts in the mean vector of high-dimensional heteroscedastic processes. …”
  17. 1357
  18. 1358
  19. 1359
  20. 1360